DNA-In® CRISPR Transfection Reagent MTI-GlobalStem’s new DNA-In® CRISPR transfection reagent delivers Cas9 in vitro with high efficiency and low toxicity to support targeted genome editing ...
When the CRISPR Cas9 protein is added to a cell along with a piece of guide RNA, the Cas9 protein hooks up with the guide RNA and then moves along the strands of DNA until it finds and binds to a ...
A plasmid encoding Cas9 nuclease, (2) a chemically-synthesized trans-activating RNA (tracRNA), and (3) a custom CRISPR RNA (crRNA) designed to target the site of interest. The Edit-R platform greatly ...
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.